Literature DB >> 6161966

Bacterial lipopolysaccharide (endotoxin) interferes with the induction of tolerance and primes thymus-derived lymphocytes.

D E Parks, S M Walker, W O Weigle.   

Abstract

The injection of deaggregated human gamma-globulin (DHGG) into mice results in the establishment of specific immunologic unresponsiveness in T and B lymphocytes. However, the additional injection of bacterial lipopolysaccharide (LPS) 3 hr later converts the tolerogenic DHGG into an immunogen for both helper T and B cells. This generation of immunocompetence to HGG during interference with tolerance induction by LPS is demonstrated by both a primary plaque-forming cell response to DHGG + LPS and a secondary antibody response to a subsequent antigenic challenge. The secondary response to antigen stimulation in the B cells is, however, T cell dependent. Interference with tolerance induction in antigen-specific helper T cells can be demonstrated by challenge with the DNP-HGG hapten-carrier conjugate or by adoptive cell transfer with primed B cells and subsequent challenge with immunogenic HGG. Furthermore, helper T cells in the spleen and thymus become primed by DHGG + LPS as evidenced by their cooperation with primed B cells in the adoptive transfer assay. In addition to its interference with tolerance induction, LPS injected with either tolerogenic or immunogenic HGG also facilitates priming of helper T cells for the response to DNP-HGG. These data indicate that exposure of antigen-specific helper T and B cells to antigen alone results in the induction of tolerance, whereas induction of immunocompetence in these cells requires at least 2 signals, 1 provided by interaction with antigen and a 2nd delivered by a nonspecific stimulus similar to that provided by LPS in the present experiments.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6161966

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Resistance to tolerance induction to human gammaglobulin (HGG) in autoimmune BXSB/MpJ mice: functional analysis of antigen-presenting cells and HGG-specific T helper cells.

Authors:  J L Garnier; R Merino; M Kimoto; S Izui
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

2.  Divergent effects of bacterial lipopolysaccharide on immunity to orally administered protein and particulate antigens in mice.

Authors:  A M Mowat; M J Thomas; S MacKenzie; D M Parrott
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

3.  In vivo activity of interleukin-2: conversion of a stimulus causing unresponsiveness to a stimulus causing contact hypersensitivity by the injection of interleukin-2.

Authors:  V Colizzi; M Malkovsky; G Lang; G L Asherson
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

4.  Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice.

Authors:  D Homann; A Tishon; D P Berger; W O Weigle; M G von Herrath; M B Oldstone
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

Review 5.  Understanding how lipopolysaccharide impacts CD4 T-cell immunity.

Authors:  Jeremy P McAleer; Anthony T Vella
Journal:  Crit Rev Immunol       Date:  2008       Impact factor: 2.214

6.  Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology.

Authors:  S Ehl; J Hombach; P Aichele; T Rülicke; B Odermatt; H Hengartner; R Zinkernagel; H Pircher
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

7.  Role of antigen-presenting cells in mediating tolerance and autoimmunity.

Authors:  K M Garza; S M Chan; R Suri; L T Nguyen; B Odermatt; S P Schoenberger; P S Ohashi
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

8.  In vivo induction of tolerance in murine CD4+ cell subsets.

Authors:  C G Romball; W O Weigle
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

9.  Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant.

Authors:  B Pulendran; J L Smith; M Jenkins; M Schoenborn; E Maraskovsky; C R Maliszewski
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.